J. Goldman & Co LP

Position in LQDA — Liquidia Corp

CIK 1412741 NEW YORK, NY

Back to LQDA Full portfolio

Position in LQDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,770,006

+$1,316,674 QoQ

Shares Held

22,200

+84.8% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#129

of 333 holders

Holding Since

Sep 2022

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Jun 30, 2026

CallValue

$4,855,557

CallShares

60,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

J. Goldman & Co LP holds $3,690,441 across 4 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (48.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp This page	22,200	$1,770,006
2	DERM	Journey Medical Corp	137,584	$974,094
3	PCRX	Pacira BioSciences, Inc.	22,078	$560,118
4	HIMS	Hims & Hers Health, Inc.	11,140	$386,223

All Filings in LQDA

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,770,006	22,200	+84.8%	Shares	Sole	2026-08-14
2026-06-30	$4,855,557	60,900	-35.6%	Call	Sole	2026-08-14
2026-03-31	$453,332	12,012	-50.3%	Shares	Sole	2026-05-15
2026-03-31	$3,566,430	94,500	+75.0%	Call	Sole	2026-05-15
2025-09-30	$549,830	24,179	—	Shares	Sole	2025-11-14
2022-09-30	$293,760	54,000	—	Call	Sole	2022-11-14
No filing history on record for this holder in this stock.